Skip to main content
Vivos Therapeutics, Inc. logo

Vivos Therapeutics, Inc. — Investor Relations & Filings

Ticker · VVOS ISIN · US92859E1082 US Manufacturing
Open in API
Filings indexed 260 across all filing types
Latest filing 2025-08-25 Regulatory Filings
Country US United States of America
Listing US VVOS

About Vivos Therapeutics, Inc.

https://vivos.com/

Vivos Therapeutics, Inc. is a medical technology company focused on developing and commercializing diagnostic and treatment methods for sleep-disordered breathing, including obstructive sleep apnea (OSA). The company's core offering is The Vivos System, a non-surgical treatment that uses proprietary oral appliances. These devices are designed to address underlying dentofacial abnormalities that can restrict the airway. The treatment protocol aims to promote the natural growth and development of the jaw and airway in both adult and pediatric patients. Vivos provides its technology and training to a network of licensed dentists and medical professionals who deliver the therapy.

Recent filings

Filing Released Lang Actions
8-K/A
Regulatory Filings Classification · 95% confidence The document is a Form 8-K/A (Amendment No. 1) filed with the SEC, which is a current report amendment. It details the completion of an acquisition by Vivos Therapeutics, Inc. of The Sleep Center of Nevada, including financial terms, agreements, and operational integration updates. The document is not a full annual or quarterly report, nor is it an earnings release or investor presentation. It is a regulatory filing reporting a material event (acquisition completion and related disclosures). The document length is substantial (15,000 characters), and it contains detailed disclosures about the acquisition and integration, but it is not a standalone audit report or management discussion of financial results. It is clearly a current report amendment (Form 8-K/A) which falls under Regulatory Filings (RNS) as it does not fit other specific categories like M&A filings (which are typically Form 425, DEFM14A, etc.) or merger proxy statements. Therefore, the best classification is Regulatory Filings (RNS).
2025-08-25 English
8-K
Earnings Release Classification · 95% confidence The document is a Form 8-K filed with the SEC, which is a Current Report used to announce significant events. The text specifically mentions Item 2.02, which is "Results of Operations and Financial Condition," and states that the company issued a press release announcing its financial results for the second quarter ended June 30, 2025. The document includes the press release as an exhibit but does not contain the full financial statements or detailed financial analysis itself. The length of the document is 4296 characters, which is relatively short and consistent with an announcement rather than a full report. According to the rules, a short document announcing the release of financial results and including a press release is classified as an Earnings Release (ER).
2025-08-20 English
10-Q
Interim / Quarterly Report Q2 2025
2025-08-19 English
NT 10-Q
Regulatory Filings Classification · 100% confidence The document is a Form 12b-25, which is a Notification of Late Filing submitted to the SEC. It specifically states that the company, Vivos Therapeutics, Inc., is unable to file its Form 10-Q for the quarter ended June 30, 2025, within the prescribed time period and requests an extension. The document does not contain the actual 10-Q report or substantive financial data but rather explains the reason for the delay and the expected filing date. According to the classification rules, such a notification is not the report itself but an announcement related to the filing status. Therefore, this document should be classified as a Regulatory Filing (RNS), which is the fallback category for filings that do not fit other specific categories and includes officer certifications, attestations, and notifications of filing delays.
2025-08-14 English
Major Shareholding Notification 2025
Major Shareholding Notification
2025-07-14 English
PRIMARY DOCUMENT
Director's Dealing
2025-06-20 English

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.